2m 2m 2m 2m 2m 2m 2m
- $1.4BMarket Cap
- 33.90%1-Year Change
- Health Information ServicesIndustry
OMADA HLTH (OMDA)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 82
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
Omada Health to Participate in Canaccord Genuity’s 46th Annual Growth Conference
Omada Health announced that senior management will participate in Canaccord Genuity's 46th annual Growth Conference in Boston on August 11, 2026, with a fireside chat. The company provides virtual healthcare services for chronic conditions and has served over two million members across 2,000+ employers and health plans.
07/13/2026, 9:00 AM • GlobeNewswire
Omada Health CEO Sean Duffy Sells 17,000 Shares. What Does This Mean for Investors?
Omada Health CEO Sean Duffy sold 17,258 shares worth approximately $342,000 between June 24-26, 2026, under a pre-established 10b5-1 trading plan adopted in March 2026. While insider selling doesn't always predict stock declines, the timing raises concerns as it occurs just 13 months after the company's IPO at $19 per share, potentially signaling reduced confidence in the business despite expected 25% sales growth.
07/02/2026, 2:36 PM • The Motley Fool
The global digital health for musculoskeletal care market is projected to grow from $3.8 billion in 2025 to $10.9 billion by 2032, with a CAGR of 16.4%. Growth is driven by rising MSK disorder prevalence, wearable device adoption, AI-powered remote physiotherapy, telehealth expansion, and increasing insurance coverage for digital MSK solutions.
06/24/2026, 9:58 AM • GlobeNewswire
Oceaneering Stock Is Up 105% in a Year, and One Fund Just Disclosed a $7 Million Bet on More Growth
Archon Capital Management disclosed a new $6.73 million position in Oceaneering International, purchasing 208,000 shares. The stock has surged 105% over the past year, significantly outperforming the S&P 500. Despite mixed recent quarterly results, the fund appears bullish on the company's diversification into aerospace, defense, and robotics sectors, with management guiding $1 billion in new orders.
05/21/2026, 6:25 PM • The Motley Fool
Voyager Stock Up 12% Post-IPO as One Fund Commits Nearly 30% of Assets
Liberty Street Advisors increased its stake in Voyager Technologies (VOYG) by 136,925 shares worth $3.71 million, bringing the company to nearly 30% of the fund's assets. Voyager's stock has risen 12% since its IPO at $31, now trading at $34.58. The investment reflects confidence in Voyager's defense and space technology business, supported by strong Q3 results including 31% growth in its Defense segment, $188.6 million backlog, and $413 million in cash with no debt.
01/24/2026, 12:03 PM • The Motley Fool
The digital health coaching market is projected to grow from $11.03 billion in 2024 to $28.40 billion by 2032, driven by AI-powered personalization, rising chronic disease rates, and increased employer wellness program adoption.
12/03/2025, 8:45 PM • GlobeNewswire
Omada Health presented research at ObesityWeek 2025 showing its behavior change program can enhance weight loss outcomes and medication persistence for GLP-1 users, with members maintaining weight loss even after discontinuing medication.
11/04/2025, 12:00 PM • GlobeNewswire
Omada Health introduces Meal Map, an AI nutrition tool focusing on nutrient quality instead of calorie counting, aiming to help members make informed food choices and develop healthier eating habits.
10/01/2025, 9:00 AM • GlobeNewswire
New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy
Omada Health's virtual physical therapy program for musculoskeletal conditions showed lower healthcare utilization and spending compared to in-person physical therapy, with median per-member savings over $100 in the first six months.
08/28/2025, 9:00 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 07/13/2026
Company Profile
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
Key Executives
- Sean Duffy
- Wei-Li Shao
- Steven L. Cook
- Tom Scales
- Allan Kells
Current Ownership Distribution
- Institutions149.3M (83.85%)
- Mutual Funds27.6M (15.48%)
- Insiders1.2M (0.66%)
- Other0 (0.00%)